Publications by authors named "R Heelan"

Claim this Profile
A
A comparison of the pathological, clinical and radiographical, features of cryptogenic organising pneumonia, acute fibrinous and organising pneumonia and granulomatous organising pneumonia.
Marc B Feinstein, Shilpa A DeSouza, Andre L Moreira, Diane E Stover, Robert T Heelan

J Clin Pathol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
Paul K Paik, Leonard P James, Gregory J Riely, Christopher G Azzoli, Vincent A Miller, Robert T Heelan

Cancer Chemother Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular characteristics predict clinical outcomes: prospective trial correlating response to the EGFR tyrosine kinase inhibitor gefitinib with the presence of sensitizing mutations in the tyrosine binding domain of the EGFR gene.
Naiyer A Rizvi, Valerie Rusch, William Pao, Jamie E Chaft, Marc Ladanyi, Robert T Heelan

Clin Cancer Res· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.
Katharine A Price, Christopher G Azzoli, Lee M Krug, Maria C Pietanza, Naiyer A Rizvi, Robert T Heelan

J Thorac Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinib.
Maureen F Zakowski, Sanaa Hussain, William Pao, Marc Ladanyi, Michelle S Ginsberg, Robert Heelan

Arch Pathol Lab Med· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis